{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:24:40Z","timestamp":1792070680126,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Lin'an Sci-Tech Guidance Project","award":["grant No. 2023Y07"],"award-info":[{"award-number":["grant No. 2023Y07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05286-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:47:19Z","timestamp":1784558839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of sodium zirconium cyclosilicate on non-dialysis days for long-term management of chronic hyperkalemia in maintenance hemodialysis: a single-center, prospective, open-label, randomized controlled trial"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"chictr2600119050","registry":"10.18810\/chictr"}],"author":[{"given":"Yan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"2","key":"5286_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2384585","volume":"46","author":"H Jin","year":"2024","unstructured":"Jin H, Lu R, Zhang L et al (2024) Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K). Ren Fail 46(2):2384585. https:\/\/doi.org\/10.1080\/0886022X.2024.2384585","journal-title":"Ren Fail"},{"issue":"7","key":"5286_CR2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/ckj\/sfaa208","volume":"14","author":"A Karaboyas","year":"2020","unstructured":"Karaboyas A, Robinson BM, James G et al (2020) Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients. Clin Kidney J 14(7):1760\u20131769. https:\/\/doi.org\/10.1093\/ckj\/sfaa208","journal-title":"Clin Kidney J"},{"issue":"42","key":"5286_CR3","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3760\/cma.j.cn112137-20210525-01203","volume":"101","author":"X Xing","year":"2021","unstructured":"Xing X, Yao L, Li Y, Zhang F, Li P, Qiao Y et al (2021) Analysis of risk factors for hyperkalemia in hemodialysis patients and development and validation of a risk assessment model of hyperkalemia. Natl Med J China 101(42):3495\u20133500. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20210525-01203","journal-title":"Natl Med J China"},{"issue":"1","key":"5286_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/0886022X.2020.1871012","volume":"43","author":"D Bem","year":"2021","unstructured":"Bem D, Sugrue D, Wilding B et al (2021) The effect of hyperkalemia and long interdialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review. Ren Fail 43(1):241\u2013254. https:\/\/doi.org\/10.1080\/0886022X.2020.1871012","journal-title":"Ren Fail"},{"issue":"1","key":"5286_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","volume":"70","author":"SM Brunelli","year":"2017","unstructured":"Brunelli SM, Du Mond C, Oestreicher N et al (2017) Serum potassium and short-term clinical outcomes among hemodialysis patients: impact of the long interdialytic interval. Am J Kidney Dis 70(1):21\u201329. https:\/\/doi.org\/10.1053\/j.ajkd.2016.10.024","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5286_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.kint.2024.10.010","volume":"107","author":"DM Charytan","year":"2025","unstructured":"Charytan DM, Winkelmayer WC, Granger CB et al (2025) Effects of dialysate potassium concentration of 3.0 mmol\/L with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol\/L alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int 107(1):169\u2013179. https:\/\/doi.org\/10.1016\/j.kint.2024.10.010","journal-title":"Kidney Int"},{"issue":"2","key":"5286_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","volume":"69","author":"A Karaboyas","year":"2017","unstructured":"Karaboyas A, Zee J, Brunelli SM, Usvyat LA et al (2017) Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 69(2):266\u2013277. https:\/\/doi.org\/10.1053\/j.ajkd.2016.09.015","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"5286_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066394","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zuo L (2023) Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol. BMJ Open 13(9):e066394. https:\/\/doi.org\/10.1136\/bmjopen-2022-066394","journal-title":"BMJ Open"},{"issue":"7","key":"5286_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/ndt\/gfx241","volume":"33","author":"SM Brunelli","year":"2018","unstructured":"Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP (2018) Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33(7):1207\u20131214. https:\/\/doi.org\/10.1093\/ndt\/gfx241","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"5286_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","volume":"4","author":"F Sacher","year":"2018","unstructured":"Sacher F, Jesel L, Borni-Duval C et al (2018) Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters. JACC Clin Electrophysiol 4(3):397\u2013408. https:\/\/doi.org\/10.1016\/j.jacep.2017.08.002","journal-title":"JACC Clin Electrophysiol"},{"key":"5286_CR11","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.2147\/RMHP.S552431","volume":"18","author":"P Wang","year":"2025","unstructured":"Wang P, Xiao JN, Liu YY et al (2025) Development and validation of a risk prediction model for interdialytic hyperkalemia in patients undergoing maintenance hemodialysis. Risk Manag Healthc Policy 18:3713\u20133724. https:\/\/doi.org\/10.2147\/RMHP.S552431","journal-title":"Risk Manag Healthc Policy"},{"issue":"5","key":"5286_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10557-020-07134-2","volume":"35","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xu R, Wang F et al (2021) Effects and safety of a novel oral potassium-lowering drug-sodium zirconium cyclosilicate for the treatment of hyperkalemia: a systematic review and meta-analysis. Cardiovasc Drugs Ther 35(5):1057\u20131066. https:\/\/doi.org\/10.1007\/s10557-020-07134-2","journal-title":"Cardiovasc Drugs Ther"},{"issue":"23","key":"5286_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235523","volume":"10","author":"T Imamura","year":"2021","unstructured":"Imamura T, Oshima A, Narang N et al (2021) Clinical implications of sodium zirconium cyclosilicate therapy in patients with systolic heart failure and hyperkalemia. J Clin Med 10(23):5523. https:\/\/doi.org\/10.3390\/jcm10235523","journal-title":"J Clin Med"},{"key":"5286_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2021.100635","volume":"95","author":"DB Shrestha","year":"2021","unstructured":"Shrestha DB, Budhathoki P, Sedhai YR et al (2021) Patiromer and sodium zirconium cyclosilicate in treatment of hyperkalemia: a systematic review and meta-analysis. Curr Ther Res Clin Exp 95:100635. https:\/\/doi.org\/10.1016\/j.curtheres.2021.100635","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"5286_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2215\/CJN.12651018","volume":"14","author":"BS Spinowitz","year":"2019","unstructured":"Spinowitz BS, Fishbane S, Pergola PE et al (2019) Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study. Clin J Am Soc Nephrol 14(6):798\u2013809. https:\/\/doi.org\/10.2215\/CJN.12651018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"5286_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1681\/ASN.2019050450","volume":"30","author":"S Fishbane","year":"2019","unstructured":"Fishbane S, Ford M, Fukagawa M et al (2019) A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia. J Am Soc Nephrol 30(9):1723\u20131733. https:\/\/doi.org\/10.1681\/ASN.2019050450","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"5286_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.clinthera.2023.04.014","volume":"45","author":"Z Ni","year":"2023","unstructured":"Ni Z, Lu R, Xu X et al (2023) DIALIZE China: a phase IIIb, randomized, placebo-controlled study to reduce predialysis hyperkalemia with sodium zirconium cyclosilicate in Chinese patients. Clin Ther 45(7):633\u2013642. https:\/\/doi.org\/10.1016\/j.clinthera.2023.04.014","journal-title":"Clin Ther"},{"issue":"10","key":"5286_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3760\/cma.j.cn441217-20200721-00139","volume":"36","author":"J Chen","year":"2020","unstructured":"Chen J, Expert Group of Chinese Society of Nephrology (2020) Expert consensus on the management of serum potassium in chronic kidney disease patients in China. Chin J Nephrol 36(10):781\u2013792. https:\/\/doi.org\/10.3760\/cma.j.cn441217-20200721-00139","journal-title":"Chin J Nephrol"},{"issue":"1","key":"5286_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","volume":"97","author":"CM Clase","year":"2020","unstructured":"Clase CM, Carrero JJ, Ellison DH et al (2020) Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 97(1):42\u201361. https:\/\/doi.org\/10.1016\/j.kint.2019.09.018","journal-title":"Kidney Int"},{"issue":"4","key":"5286_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2025.06.016","volume":"108","author":"S Fishbane","year":"2025","unstructured":"Fishbane S, Dember LM, Jadoul M et al (2025) The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis. Kidney Int 108(4):686\u2013694. https:\/\/doi.org\/10.1016\/j.kint.2025.06.016","journal-title":"Kidney Int"},{"issue":"3","key":"5286_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000448341","volume":"44","author":"AA Yusuf","year":"2016","unstructured":"Yusuf AA, Hu Y, Singh B et al (2016) Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study. Am J Nephrol 44(3):179\u2013186. https:\/\/doi.org\/10.1159\/000448341","journal-title":"Am J Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05286-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:25:04Z","timestamp":1788960304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05286-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":21,"alternative-id":["5286"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05286-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional ethics committee of The First People's Hospital of Lin'an District (approval No.2023-27).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}